The Effects of Methylphenidate on Ventricular Repolarization Parameters in Children with Attention-Deficit Hyperactivity Disorder

被引:4
|
作者
Tanir, Yasar [1 ]
Erbay, Muhammed Furkan [1 ]
Ozkan, Selcuk [2 ]
Ozdemir, Rahmi [3 ]
Orengul, Abdurrahman Cahid [1 ]
机构
[1] Istanbul Univ, Istanbul Med Fac, Dept Child & Adolescent Psychiat, Istanbul, Turkiye
[2] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Child & Adolescent Psychiat, Kutahya, Turkiye
[3] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Pediat Cardiol, Kutahya, Turkiye
来源
ALPHA PSYCHIATRY | 2023年 / 24卷 / 05期
关键词
Attention-deficit hyperactivity disorder; cardiovascular effects; electrocardiog-raphy; methylphenidate; children; T-END INTERVAL; DEFICIT/HYPERACTIVITY DISORDER; RELEASE METHYLPHENIDATE; RISK; RISPERIDONE; ADHD; PEAK; ADOLESCENTS; DISPERSION; THERAPY;
D O I
10.5152/alphapsychiatry.2023.231185
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Long-acting methylphenidate (MPH), a psychostimulant agent, is widely used in the treatment of attention-deficit hyperactivity disorder (ADHD). Methylphenidate might cause an increment in the risk of lethal arrhythmias by deteriorating ventricular repolarization. QT intervals, the corrected QT (QTc), QT dispersion, T-peak to T-end (TpTe), and the TpTe/QTc ratio are the most utilized indicators of ventricular repolarization in electrocardiogram (ECG). The present study was conducted to examine the effects of long-term MPH use on the ECG in pediatric patients.Methods: A total of 52 children with ADHD and 51 age- and gender-matched controls were enrolled in the study. The children had been using MPH regularly for at least 6 months. Comparisons were made regarding ECG parameters, including the mean intervals of QT, QTc, QTc dispersion interval duration, TpTe intervals, TpTe/QT, and TpTe/QTc ratio.Results: The median duration of treatment with MPH was 30 months (minimum-maximum: 6-120), and the median MPH dose was 30 mg/day (minimum-maximum: 18-54). The main findings showed significantly prolonged P-wave dispersion, TpTe interval, TpTe dispersion, and TpTe/QT and TpTe/QTc ratios in the ADHD group compared to the healthy controls (P < .001). These parameters were not associated with MPH dose or treatment duration. Additionally, nearly half of the patients had QTc values of 460 ms or higher, but there were no significant differences in treatment duration and dose compared to the remaining group (P = .792 and P = .126).Conclusion: Methylphenidate may have proarrhythmogenic effects in children with ADHD, which may not be adversely affected by long-term use and treatment dose. Considering the extensive use of MPH, cardiac monitoring of these children is important.
引用
收藏
页数:66
相关论文
共 50 条
  • [41] Effects of methylphenidate on EEG coherence in Attention-Deficit/Hyperactivity Disorder
    Clarke, AR
    Barry, RJ
    McCarthy, R
    Selikowitz, M
    Johnstone, SJ
    Abbott, I
    Croft, RJ
    Magee, CA
    Hsu, CI
    Lawrence, CA
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2005, 58 (01) : 4 - 11
  • [42] Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
    Turner, DC
    Blackwell, AD
    Dowson, JH
    McLean, A
    Sahakian, BJ
    PSYCHOPHARMACOLOGY, 2005, 178 (2-3) : 286 - 295
  • [43] The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder
    DeVito, Elise E.
    Blackwell, Andrew D.
    Kent, Lindsey
    Ersche, Karen D.
    Clark, Luke
    Salmond, Claire H.
    Dezsery, Anna Maria
    Sahakian, Barbara J.
    BIOLOGICAL PSYCHIATRY, 2008, 64 (07) : 636 - 639
  • [44] Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder
    Wilens, Timothy E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : S46 - S53
  • [45] A DIVIDED ATTENTION ANALYSIS OF THE EFFECTS OF METHYLPHENIDATE ON THE ARITHMETIC PERFORMANCE OF CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    CARLSON, CL
    PELHAM, WE
    SWANSON, JM
    WAGNER, JL
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, 1991, 32 (03): : 463 - 471
  • [46] Methylphenidate in the treatment of children and adolescents with bipolar disorder and Attention-Deficit/Hyperactivity disorder
    Findling, Robert L.
    Short, Elizabeth J.
    McNamara, Nora K.
    Demeter, Christine A.
    Stansbrey, Robert J.
    Gracious, Barbara L.
    Whipkey, Resaca
    Manos, Michael J.
    Calabrese, Joseph R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (11): : 1445 - 1453
  • [47] Experiences of children and adolescents with attention-deficit/hyperactivity disorder taking methylphenidate
    Jacobs, Delphine
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2023, 65 (12): : 1587 - 1595
  • [48] The Effect of Methylphenidate on Executive Functions in Children with Attention-Deficit Hyperactivity Disorder
    Yilmaz, Alper
    Gokcen, Cem
    Fettahoglu, Emine Cigil
    Ozatalay, Esin
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 23 (02): : 162 - 170
  • [49] Effect of OROS Methylphenidate on Encopresis in Children with Attention-Deficit/Hyperactivity Disorder
    Yilmaz, Savas
    Bilgic, Ayhan
    Herguner, Sabri
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (03) : 158 - 160
  • [50] Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate
    Thomas Fuchs
    Niels Birbaumer
    Werner Lutzenberger
    John H. Gruzelier
    Jochen Kaiser
    Applied Psychophysiology and Biofeedback, 2003, 28 : 1 - 12